Home
Drugs
Prednisone
Clinical Trials

Clinical Trials Related to Prednisone

Related studies linked through entity extraction aliases.

A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Study to Evaluate the Tolerability, Safety, Pharmacokinetics, and Antitumor Activity of Loncastuximab Tesirine in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated Diffuse Large B-cell Lymphoma (LOTIS-8)

Status: WITHDRAWN
Phase: PHASE1

Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer

Status: RECRUITING
Phase: PHASE2

Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas

Status: TERMINATED
Phase: PHASE1

Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

Status: RECRUITING
Phase: PHASE2

The Clinical Features and Pregnancy Outcomes of CTD Patients

Status: RECRUITING
Phase: N/A

Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)

Status: TERMINATED
Phase: PHASE2

Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China Extension

Status: TERMINATED
Phase: PHASE3

Selective CD28 Blockade in Renal Transplant Recipients

Status: WITHDRAWN
Phase: PHASE2

Zanubrutinib Combined With R-CHOP in Newly-diagnosed Intravascular Large B-cell Lymphoma

Status: UNKNOWN
Phase: PHASE2

TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer

Status: COMPLETED
Phase: PHASE3

Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma

Status: RECRUITING
Phase: PHASE1

Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis

Status: UNKNOWN
Phase: NA

Venetoclax, Dasatinib, Prednisone, Rituximab and Blinatumomab for the Treatment of Newly Diagnosed or Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia or Mixed Phenotype Acute Leukemia

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Zanubrutinib in Combination With R-PolaCHP (ZaR-PolaCHP) for Newly Diagnosed Diffuse Large B-Cell Lymphoma

Status: SUSPENDED
Phase: PHASE1

Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation

Status: SUSPENDED
Phase: PHASE2

Zanubrutinib Plus R-CHOP for Patients With Newly Diagnosed Untreated Non-GCB DLBCL

Status: UNKNOWN
Phase: PHASE2

rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease

Status: ENROLLING_BY_INVITATION
Phase: PHASE1/PHASE2